Status:
WITHDRAWN
Homeopathic Protocol for Advanced Breast Cancer
Lead Sponsor:
Meir Medical Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The objective of this study is to conduct a feasibility study at Meir Oncology Institute examining whether patients with advanced breast cancer would follow a homeopathic protocol for three to six mon...
Detailed Description
\- Homeopathy is a controversial system of care and at the center of the controversy lays the question of whether high dilution remedies can be effective. There have been only a handful of high quali...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Ability to speak and read Hebrew/English with patients residing in Israel.
- Diagnosis of advanced breast cancer treated and followed in Meir Oncology Institute
- Patients that cannot participate in conventional cancer care due to side effects, expected adverse reactions or other reasons that prevent them from utilizing conventional care.
- Patients, who for their own reasons elect to refuse conventional treatment, can be offered to participate in the study in order to keep them in the system and not lose them to alternative untested treatments.
- Consent to participate in this study
Exclusion
- Inability to understand the intent of the study and follow the instructions
- Medical condition that would preclude participation in an interview session lasting 15-30 minutes
- Diagnosis of active psychosis or severe cognitive impairment confirmed by the patient's attending physician.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02190539
Start Date
August 1 2014
End Date
August 1 2019
Last Update
August 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Oncology Meir Medical Center
Kfar Saba, Israel